MedTrace Logo

Performance of the ePrime System for Cellulite

NCT02489994 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2016-03-18

No results posted yet for this study

Summary

Clinical Study to Evaluate the Performance of the ePrime System for the Treatment of Cellulite.

Conditions

  • Cellulite

Interventions

DEVICE

ePrime

The main intent of the ePrime for cellulite is to utilize a minimally-invasive approach to directly deliver RF energy into tissue through pairs of micro-electrode needles and use temperature sensors within the needles to reliably create fractional thermal injuries within the skin.

Sponsors & Collaborators

  • Syneron Medical

    lead INDUSTRY

Principal Investigators

  • Macrene Alexiades, MD · Dermatology and Laser Surgery Center 955 Park Avenue, New York, NY, 10028

  • Leyda Bowes, MD · Bowes Dermatology, 3659 South Miami Avenue, Suite # 6008, Miami, FL 33133

  • David Goldberg, MD · Skin Laser & Surgery Specialist of NY/NJ

  • Girish Munavalli, MD · Laser & Vein Specialists of the Carolinas, 1918 Randolph Road, Suite 550, Charlotte, NC 28270

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-08-31
Completion
2016-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02489994 on ClinicalTrials.gov